Welcome to our ninth annual report on US securities class actions filed against publicly traded life sciences companies, which include pharmaceutical, biotechnology, medical device, and healthcare companies....more
3/31/2025
/ Biotechnology ,
Class Action ,
Clinical Trials ,
FDA Approval ,
Health Care Providers ,
Insider Trading ,
Life Sciences ,
Medical Devices ,
Medicare ,
Motion to Dismiss ,
Pharmaceutical Industry ,
Publicly-Traded Companies ,
Scienter ,
Securities and Exchange Commission (SEC) ,
Securities Exchange Act of 1934 ,
Securities Fraud ,
Securities Litigation
On September 21, 2022, U.S. District Judge George B. Daniels of the Southern District of New York dismissed with prejudice a putative securities class action against BELLUS Health, Inc. and certain of its officers....more
10/10/2022
/ Cannabis Products ,
CFTC ,
Cryptocurrency ,
Data Preservation ,
Dismissal With Prejudice ,
Dismissals ,
Electronic Devices ,
Elon Musk ,
Enforcement Actions ,
Insider Trading ,
Investment Advisers Act of 1940 ,
Pay-To-Play ,
Public Statements ,
Putative Class Actions ,
Recordkeeping Requirements ,
Rule 10b-5 ,
Securities Act of 1933 ,
Securities and Exchange Commission (SEC) ,
Securities Exchange Act ,
Securities Litigation ,
Shareholder Litigation ,
Twitter ,
Unregistered Securities